发明名称 |
Processes for the preparation of highly pure Rivaroxaban crystal modification I |
摘要 |
Provided herein are improved, commercially viable and consistently reproducible processes for the preparation of highly pure crystal Modification I of Rivaroxaban, which is free from other polymorphs and undesired solvated forms. Provided also herein is a highly pure and stable crystal Modification I of Rivaroxaban essentially free of other solid state forms. |
申请公布号 |
US9469628(B2) |
申请公布日期 |
2016.10.18 |
申请号 |
US201514601419 |
申请日期 |
2015.01.21 |
申请人 |
Symed Labs Limited |
发明人 |
Dodda Mohan Rao;Bingi Venugopal |
分类号 |
C07D413/14 |
主分类号 |
C07D413/14 |
代理机构 |
Caesar Rivise, PC |
代理人 |
Caesar Rivise, PC |
主权项 |
1. A process for the preparation of Crystal Modification I of Rivaroxaban, comprising:
a) providing a solution of Rivaroxaban in a solvent medium comprising water and acetone at an ambient temperature; b) optionally, subjecting the solution obtained in step-(a) to carbon treatment to obtain a filtrate; c) cooling the solution obtained in step-(a) or step-(b) at a temperature of below about 35° C. to cause crystallization; and d) recovering highly pure crystal Modification I of Rivaroxaban formed in step-(c). |
地址 |
IN |